Literature DB >> 24033801

Markers of iron metabolism in retired racing Greyhounds with and without osteosarcoma.

J T Caro1, L M Marín, M C Iazbik, S Zaldivar-López, H Borghese, C G Couto.   

Abstract

BACKGROUND: Greyhounds have well-described clinicopathologic idiosyncrasies, including a high prevalence of osteosarcoma (OSA). Hematocrit, HGB, and HGB oxygen affinity are higher than in other dogs, while haptoglobin concentration is lower, so we hypothesized that Greyhounds have a different iron metabolism. To our knowledge, there are no reports on serum iron profiles in Greyhounds.
OBJECTIVES: To elucidate iron metabolism in Greyhounds, we wanted to compare serum iron concentration, total iron-binding capacity (TIBC), and percent transferrin saturation (%SAT) in healthy retired racing Greyhounds (RRGs) with OSA (RRGs - OSA), and also with non-Greyhounds (NGs), without and with OSA (NGs - OSA).
METHODS: Serum iron concentration and unsaturated iron-binding capacity (UIBC) were measured by standard methods, and TIBC and %SAT were calculated in RRGs (n = 25), RRGs - OSA (n = 28), NGs (n = 30), and NGs - OSA (n = 32).
RESULTS: TIBC was lower in RRGs than in NGs (P < .0001), and in RRGs - OSA than in NGs - OSA (P < .0001). NGs - OSA had lower TIBC than healthy NGs (P = .003). Percent SAT was higher in RRGs than in NGs (P < .0001) and in RRGs - OSA (P = .008), and %SAT was also lower in NGs than in NGs - OSA (P = .004). Percent SAT was also higher in RRGs - OSA than in NGs - OSA (P = .001). Both RRGs - OSA (P = .02) and NGs - OSA (P < .0001) had lower serum iron concentrations than their healthy counterparts.
CONCLUSION: Lower TIBC and higher %SAT may constitute another Greyhound idiosyncrasy compared with other dogs. In this study, all dogs with OSA had higher serum iron concentrations and %SAT than healthy dogs.
© 2013 American Society for Veterinary Clinical Pathology.

Entities:  

Keywords:  Dihydroartemisinin; iron sequestration; percent transferrin saturation; serum iron concentration; total iron-binding capacity

Mesh:

Substances:

Year:  2013        PMID: 24033801      PMCID: PMC4120296          DOI: 10.1111/vcp.12066

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  17 in total

1.  Serum protein electrophoresis in retired racing Greyhounds.

Authors:  Manena Fayos; C Guillermo Couto; María Cristina Iazbik; Maxey L Wellman
Journal:  Vet Clin Pathol       Date:  2005-12       Impact factor: 1.180

Review 2.  Assessing iron status: beyond serum ferritin and transferrin saturation.

Authors:  Jay B Wish
Journal:  Clin J Am Soc Nephrol       Date:  2006-09       Impact factor: 8.237

3.  Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma.

Authors:  K J Kazmierski; G K Ogilvie; M J Fettman; S E Lana; J A Walton; R A Hansen; K L Richardson; D W Hamar; C L Bedwell; G Andrews; S Chavey
Journal:  J Vet Intern Med       Date:  2001 Nov-Dec       Impact factor: 3.333

4.  Transferrin saturation, dietary iron intake, and risk of cancer.

Authors:  Arch G Mainous; James M Gill; Charles J Everett
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

5.  Determination of the lifespan of erythrocytes from greyhounds, using an in vitro biotinylation technique.

Authors:  M S Novinger; P S Sullivan; T P McDonald
Journal:  Am J Vet Res       Date:  1996-05       Impact factor: 1.156

Review 6.  Clinical pathology of Greyhounds and other sighthounds.

Authors:  S Zaldívar-López; L M Marín; M C Iazbik; N Westendorf-Stingle; S Hensley; C G Couto
Journal:  Vet Clin Pathol       Date:  2011-10-24       Impact factor: 1.180

7.  Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.

Authors:  Kenji Hosoya; Sridhar Murahari; Albert Laio; Cheryl A London; C Guillermo Couto; William C Kisseberth
Journal:  Am J Vet Res       Date:  2008-04       Impact factor: 1.156

Review 8.  Clinical application of reticulocyte counts in dogs and cats.

Authors:  Elizabeth S Cowgill; Jennifer A Neel; Carol B Grindem
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-11       Impact factor: 2.093

9.  Results of a web-based health survey of retired racing Greyhounds.

Authors:  Linda K Lord; Jill E Yaissle; Liliana Marin; C Guillermo Couto
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

Review 10.  Role of iron in carcinogenesis: cancer as a ferrotoxic disease.

Authors:  Shinya Toyokuni
Journal:  Cancer Sci       Date:  2008-10-23       Impact factor: 6.716

View more
  4 in total

Review 1.  Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.

Authors:  Siobhan Simpson; Mark David Dunning; Simone de Brot; Llorenç Grau-Roma; Nigel Patrick Mongan; Catrin Sian Rutland
Journal:  Acta Vet Scand       Date:  2017-10-24       Impact factor: 1.695

2.  Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma.

Authors:  Ying Shen; Bin Zhang; Yanwei Su; Shaikh Atik Badshah; Xiaofei Wang; Xin Li; Yanru Xue; Li Xie; Zhe Wang; Zhouqi Yang; Ge Zhang; Peng Shang
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810

3.  The Effect of Multispecies Probiotic Supplementation on Iron Status in Rats.

Authors:  Katarzyna Skrypnik; Paweł Bogdański; Marcin Schmidt; Joanna Suliburska
Journal:  Biol Trace Elem Res       Date:  2019-02-12       Impact factor: 3.738

4.  Iron status in blood donor dogs.

Authors:  S Zaldívar-López; M C Iazbik; L M Marín; C G Couto
Journal:  J Vet Intern Med       Date:  2014 Jan-Feb       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.